semaglutide for seniors the first time, Medicare will cover GLP-1s for obesity-related weight loss, without any other medical conditions. Starting Wednesday, eligible Medicare beneficiaries can receive GLP-1s for obesity for $50 per month by The Bridge program has exclusions

Novo Nordisks semaglutide pulled in sales in 2023 of DKK 96 billion ($14 billion) through diabetes drug Ozempic and DKK 31 billion ($4.5 billion) for weight loss drug Wegovy, and, with no end to demand in sight, sales are expected to increase as both more capacity comes online and more indications win approval

Clinical Update 9/16/2024 Eggshell Membrane for Osteoarthritis

Nanoparticles in the diagnosis and treatment of vascular aging and related diseases

Whether its late nights, busy schedules, or high-pressure environments, many people are looking for smarter ways to recover faster, think clearer, and feel better without waiting days to bounce back

During your consultation, your provider will assess your health profile comprehensively to recommend the best treatment plan considering your insurance coverage and personal preferences

Critical Considerations and Potential Downsides It would be irresponsible to discuss the potential synergies without an unflinching look at the complexities and risks involved in such research